Tag: SOP governance pharma

Risks of Using Outdated SOPs Post Regulatory Change in Pharma

Risks of Using Outdated SOPs Post Regulatory Change in Pharma Regulatory Compliance Risks of Continuing SOP Use After Regulation Changes Introduction to the Audit Finding 1. SOPs Must Reflect Current Regulations Using outdated procedures after a change in pharmaceutical regulations is a common but serious GMP violation. 2. Regulatory Expectations Are Dynamic Regulatory bodies like…

GMP Audit Findings, Regulatory Change

No Documented SOP Assessment Post Regulatory Updates: A Major GMP Oversight

No Documented SOP Assessment Post Regulatory Updates: A Major GMP Oversight GMP Risks of Skipping SOP Assessments After Regulatory Changes Introduction to the Audit Finding 1. Regulatory Changes Are Constant Health authorities worldwide frequently revise GMP standards, including FDA, EMA, WHO, and CDSCO updates. 2. SOPs Must Stay Current Every regulatory update should trigger a…

GMP Audit Findings, Regulatory Change

SOP Writing for Multinational Sites: Harmonization and Localization Strategies

SOP Writing for Multinational Sites: Harmonization and Localization Strategies How to Harmonize and Localize SOPs Across Multinational Pharma Sites Pharmaceutical companies operating across multiple countries face a unique challenge—how to ensure SOPs remain consistent across sites while complying with regional regulatory nuances. SOP writing for multinational sites requires a strategic balance between harmonization and localization….

SOP Development, SOP Guidelines